[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nuvation Bio Inc (NUVB)

Nuvation Bio Inc (NUVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nuvation Bio Inc 1500 BROADWAY SUITE 1401 NEW YORK NY 10036 USA

www.nuvationbio.com Employees: 298 P: 332-208-6102

Sector:

Medical

Description:

Nuvation Bio Inc. is a biopharmaceutical company. It engages in developing differentiated and novel therapeutic candidates for unmet needs in oncology. Nuvation Bio Inc., formerly known as Panacea Acquisition Corp., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 1,504,233
Enterprise Value, $K 1,393,073
Shares Outstanding, K 348,202
Float, K 243,358
% Float 69.89%
Short Interest, K 50,297
Short Float 14.47%
Days to Cover 19.01
Short Volume Ratio 0.78
% of Insider Shareholders 30.11%
% of Institutional Shareholders 61.67%

Financials:

Annual Sales, $ 62,900 K
Annual Net Income, $ -204,630 K
Last Quarter Sales, $ 83,230 K
Last Quarter Net Income, $ 5,400 K
EBIT, $ -150,180 K
EBITDA, $ -147,780 K

Growth:

1-Year Return 92.86%
3-Year Return 165.03%
5-Year Return -69.05%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -160.87%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.01 on 05/04/26
Next Earnings Date 08/06/26
Earnings Per Share ttm -0.43
EPS Growth vs. Prev Qtr 109.09%
EPS Growth vs. Prev Year 106.25%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NUVB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -44.10%
Return-on-Assets % -23.80%
Profit Margin % -325.33%
Debt/Equity 0.17
Price/Sales 26.13
Price/Cash Flow N/A
Price/Book 5.14
Book Value/Share 0.92
Interest Coverage -13.96
60-Month Beta 1.51
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.